Search
cefdinir (Omnicef)
Indications:
- treatment of bacterial infections including: pneumonia, bronchitis, ear infections, sinusitis, pharyngitis, tonsillitis, & skin infections
- empiric treatment of fever of unknown origin [2]
Dosage:
- 300 mg PO BID
Capsules: 300 mg
Solution: 25 mg/mL
Dosage adjustment in renal failure:
- eGFR < 30 mL/min 300 mg QD
Antimicrobial activity:
- Streptococcus
- Streptococcus pneumoniae
- Streptococcus pyogenes
- Haemophilus influenzae
- Haemophilus parainfluenzae
- Moraxella catarrhalis
- Staphylococcus aureus [2]
Adverse effects:
- dyspepsia
- vomiting
- loss of appetite
- diarrhea
- headache
- dizziness
- fatigue
- rash
- hives
- swelling of the face, eyes, lips, tongue, arms, or legs
- difficulty breathing or swallowing
- vaginal infection
Interactions
drug adverse effects of cephalosporins
General
cephalosporin, 3rd generation
Database Correlations
PUBCHEM cid=
References
- Omnicef Cefdinir capsules
https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050739s015,050749s021lbl.pdf
- Deprecated Reference